Relationships among smoking, oxidative stress, inflammation, macromolecular damage, and cancer
They target populations where GLP-1 therapy has the strongest evidence for reducing serious health complications, not just promoting weight loss
8,9 Hanberg JS et al
However, individual responses vary widely, and some patients tolerate or prefer semaglutide's single-pathway approach due to fewer side effects or better GI tolerability
Although there is little doubt about the benefits of these medications at this point, two main sticking points limit their broader appeal: They are expensive and require a weekly injection
A few reviewers claim the compounded semaglutide "did nothing at all." Individual responses to GLP-1 medications vary, and compounded formulations can differ in potency between batches